Decoding the Gut-Brain Axis in Alzheimer's Disease: Emerging Perspectives

Area of Science:

• Neuroscience
• Microbiology
• Immunology

Background:

• Alzheimer's disease (AD) is a major cause of dementia, characterized by cognitive decline, tau tangles, and amyloid plaques.
• The gut-brain axis, involving microbial, neuronal, and immune factors, is increasingly recognized in AD pathogenesis.
• Gut dysbiosis can increase intestinal permeability, activate immune cells, and impair the blood-brain barrier, leading to neuroinflammation and neuronal damage.

Purpose of the Study:

• To explore the association between Alzheimer's disease and gut microbiota.
• To discuss therapeutic strategies targeting gut dysbiosis for AD.

Main Methods:

• Review of experimental and clinical data on gut microbiota and AD.
• Analysis of mechanisms linking gut dysbiosis to neuroinflammation and AD pathology.

Main Results:

• Gut microbiota composition and host interactions play a significant role in AD.
• Bacterial amyloid formation and altered gut barrier function are implicated in AD.
• Dysbiosis contributes to neuroinflammation and neuronal loss observed in Alzheimer's disease.

Conclusions:

• The gut microbiota is a critical factor in Alzheimer's disease development.
• Inhibiting gut dysbiosis presents a promising therapeutic avenue for Alzheimer's disease.
• Further research into the gut-brain axis is crucial for understanding and treating AD.